Skip to main content

Medtronic buying Affera for nearly $1B in deal for cardiac-mapping tech

Medtronic is starting off 2022 with a nearly $1 billion M&A deal, announcing its plan to buy Affera Inc., a maker of cardiac mapping and navigation tools and ablation technology used to treat atrial fibrillation.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.